| For: | Méndez S, Ramay BM, Aguilar-González A, Lou-Meda R. Exploring the safety and efficacy of adding ketoconazole to tacrolimus in pediatric renal transplant immunosuppression. World J Transplant 2020; 10(11): 356-364 [PMID: 33312896 DOI: 10.5500/wjt.v10.i11.356] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v10/i11/356.htm |
| Number | Citing Articles |
| 1 |
Abhijit M. Konnur, Sishir Gang, Nitiraj Shete. A Study to Determine Outcomes, Safety, and Efficacy of Diltiazem and Azole Co-therapy with Calcineurin Inhibitors after Renal Transplantation. Indian Journal of Transplantation 2026; 20(3) doi: 10.4103/ijot.ijot_33_26
|
| 2 |
Satoshi Inaba, Hisatoshi Okumura, Tatsuya Aoki, Atsushi Kawashima. Calcineurin‐inhibitor induced pain syndrome due to interaction with clarithromycin: A case report. Journal of General and Family Medicine 2025; 26(2) doi: 10.1002/jgf2.769
|
| 3 |
Smita Pattanaik, Caroline Monchaud. Pharmacokinetic Boosting of Calcineurin Inhibitors in Transplantation: Pros, Cons, and Perspectives. Therapeutic Drug Monitoring 2025; 47(1) doi: 10.1097/FTD.0000000000001288
|
| 4 |
Fernando De la Garza Salazar. From Interaction to Intervention: Intentional CYP Inhibition as a Scalable Strategy to Expand Access to High-Cost Therapies. European Journal of Drug Metabolism and Pharmacokinetics 2026; 51(1) doi: 10.1007/s13318-025-00976-x
|
| 5 |
Sananda Bag, Subal Kumar Pradhan. Therapeutic Challenges of Tacrolimus Dose Requirement and Trough Level in an Indian Pediatric Renal Transplant Recipient with Extensive Metabolizer (Cytochrome P450 3A5*1). Indian Journal of Transplantation 2023; 17(1) doi: 10.4103/ijot.ijot_63_22
|